Pharmacological postconditioning protects against hepatic ischemia/reperfusion injury

Liver Transplantation

Volumn 17, Issue 4, 2011, Pages 474-482

  Dal Ponte, Caterina ^a   Alchera, Elisa ^a   Follenzi, Antonia ^a   Imarisio, Chiara ^a   Prat, Maria ^a   Albano, Emanuele ^a   Carini, Rita ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ALANINE AMINOTRANSFERASE; DIPOTASSIUM BISPEROXO (5 HYDROXYPYRIDINE 2 CARBOXYL)OXOVANADATE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN INHIBITOR; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG; WORTMANNIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IN VIVO STUDY; ISCHEMIC POSTCONDITIONING; LIVER ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION; REPERFUSION INJURY;

ADENOSINE; ADENOSINE A2 RECEPTOR AGONISTS; ANIMALS; LIVER; MALE; OXIDATIVE STRESS; PHENETHYLAMINES; PTEN PHOSPHOHYDROLASE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 79953181656     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22256     Document Type: Article

References (46)

1. Selzner N, Rudiger H, Graf R, Clavien PA,. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936. (Pubitemid 37070708)
2. de Rougemont O, Lehmann K, Clavien PA,. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl 2009; 15: 1172-1182.
3. Serracino-Inglott F, Habib NA, Mathie R,. Hepatic ischemia-reperfusion injury. Am J Surg 2001; 181: 160-166. (Pubitemid 32406311)
4. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W,. A prospective randomized study in 100 patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238: 843-850.
5. Banga NR, Homer-Vanniasinkam S, Graham A, Al-Mukhtar A, White SA, Prasad KR,. Ischemic preconditioning in transplantation and major resection of the liver. Br J Surg 2005; 92: 528-538. (Pubitemid 40685646)
6. Varotti G, Grazi GL, Vetrone G, Ercolani G, Cescon M, Del Gaudio M, et al. Causes of early acute graft failure after liver transplantation: analysis of a 17-year single-centre experience. Clin Transplant 2005; 19: 492-500. (Pubitemid 40990659)
7. Carini R, Albano E,. Recent insights on the mechanisms of liver preconditioning. Gastroenterology 2003; 125: 1480-1491. (Pubitemid 37409769)
8. Carini R, Grazia De Cesaris M, Splendore R, Baldanzi G, Nitti MP, Alchera E, et al. Role of phosphatidylinositol 3-kinase in the development of hepatocyte preconditioning. Gastroenterology 2004; 127: 914-923. (Pubitemid 39208423)
9. Cescon M, Carini R, Grazi G, Caraceni P, Alchera E, Gasloli G, et al. Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. J Hepatol 2009; 50: 937-947.
10. Tamguney T, Stokoe D,. New insights into PTEN. J Cell Sci 2007; 120: 4071-4079.
11. Gericke A, Munson M, Ross AH,. Regulation of the PTEN phosphatase. Gene 2006; 374: 1-9. (Pubitemid 43737118)
12. DeOliveira ML, Graf R, Clavien PA,. Ischemic preconditioning: promises from the laboratory to patients-sustained or disillusioned ? Am J Transplant 2008; 8: 489-491. (Pubitemid 351287528)
13. Gurusamy KS, Kumar Y, Sharma D, Davidson BR,. Ischaemic preconditioning for liver transplantation. Cochrane Database Syst Rev 2008; 1:CD006315.
14. Hausenloy DJ, Yellon DM,. Preconditioning and postconditioning: underlying mechanisms and clinical application. Atherosclerosis 2009; 204: 334-341.
15. Granfeldt A, Lefer DJ, Vinten-Johansen J,. Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res 2009; 83: 234-246.
16. Peart JN, Headrick JP,. Clinical cardioprotection and the value of conditioning responses. Am J Physiol Heart Circ Physiol 2009; 296: H1705-H1720.
17. Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010; 87: 406-423.
18. Wang KX, Hu SY, Jiang XS, Zhu M, Jin B, Zhang GY, Chen B,. Protective effects of ischaemic postconditioning on warm/cold ischaemic reperfusion injury in rat liver: a comparative study with ischaemic preconditioning. Chin Med J (Engl) 2008; 121: 2004-2009.
19. Wang N, Lu JG, He XL, Li N, Qiao Q, Yin JK, Ma QJ,. Effects of ischemic postconditioning on reperfusion injury in rat liver grafts after orthotopic liver transplantation. Hepatol Res 2009; 39: 382-390.
20. Zhang WX, Yin W, Zhang L, Wang LH, Bao L, Tuo HF, et al. Preconditioning and postconditioning reduce hepatic ischemia-reperfusion injury in rats. Hepatobiliary Pancreat Dis Int 2009; 8: 586-590.
21. Carini R, De Cesaris MG, Splendore R, Vay D, Domenicotti C, Nitti MP, et al. Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. HEPATOLOGY 2001; 33: 131-139. (Pubitemid 32016895)
22. Nakayama H, Yamamoto Y, Kume M, Yamagami K, Yamamoto H, Kimoto S, et al. Pharmacologic stimulation of adenosine A2 receptor supplants ischemic preconditioning in providing ischemic tolerance in rat livers. Surgery 1999; 126: 945-954. (Pubitemid 29523335)
23. Benten D, Follenzi A, Bhargava KK, Kumaran V, Palestro CJ, Gupta S,. Hepatic targeting of transplanted liver sinusoidal endothelial cells in intact mice. HEPATOLOGY 2005; 42: 140-148. (Pubitemid 40911321)
24. Gores GJ, Nieminen AL, Fleishman KE, Dawson TL, Herman B, Lemasters JJ,. Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes. Am J Physiol 1988; 255: C315-C322.
25. Shi DY, Liu HL, Stern JS, Yu PZ, Liu SL,. Alpha-lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway. FEBS Lett 2008; 582: 1667-1671.
26. Carmona-Cuenca I, Roncero C, Sancho P, Caja L, Fausto N, Fernández M, Fabregat I,. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity. J Hepatol 2008; 49: 965-976.
27. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP,. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 2003; 22: 5501-5510. (Pubitemid 37279959)
28. Leto TL, Morand S, Hurt D, Ueyama T,. Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases. Antioxid Redox Signal 2009; 11: 2607-2619.
29. Reinehr R, Becker S, Keitel V, Eberle A, Grether-Beck S, Haussinger D,. Bile salt-induced apoptosis involves NADPH oxidase isoform activation. Gastroenterology 2005; 129: 2009-2031. (Pubitemid 41772977)
30. de Mochel NS, Seronello S, Wang SH, Ito C, Zheng JX, Liang TJ, et al. Hepatocyte NAD(P)H oxidases as an endogenous source of reactive oxygen species during hepatitis C virus infection. HEPATOLOGY 2010; 52: 47-59.
31. Kreuzer J, Viedt C, Brandes RP, Seeger F, Rosenkranz AS, Sauer H, et al. Platelet-derived growth factor activates production of reactive oxygen species by NAD(P)H oxidase in smooth muscle cells through Gi1,2. FASEB J 2003; 17: 38-40.
32. Schmid AC, Byrne RD, Vilar R, Woscholski R,. Bisperoxovanadium compounds are potent PTEN inhibitors. FEBS Lett 2004; 566: 35-38. (Pubitemid 38625928)
33. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation 2005; 112: 2143-2148. (Pubitemid 41475808)
34. Peralta C, Hotter G, Closa D, Prats N, Xaus C, Gelpí E, Rosellõ-Catafau J,. The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. HEPATOLOGY 1999; 29: 126-132. (Pubitemid 29023994)
35. Lappas CM, Day YJ, Marshall MA, Engelhard VH, Linden J,. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J Exp Med 2006; 203: 2639-2648. (Pubitemid 44833340)
36. Ben-Ari Z, Pappo O, Sulkes J, Cheporko Y, Vidne BA, Hochhauser E,. Effect of adenosine A2A receptor agonist (CGS) on ischemia/reperfusion injury in isolated rat liver. Apoptosis 2005; 10: 955-962. (Pubitemid 41285575)
37. Minor T, Akbar S, Yamamoto Y,. Adenosine A2 receptor stimulation protects the predamaged liver from cold preservation through activation of cyclic adenosine monophosphate-protein kinase A pathway. Liver Transpl 2000; 6: 196-200. (Pubitemid 30174000)
38. Baldanzi G, Alchera E, Imarisio C, Gaggianesi M, Dal Ponte C, Nitti M, et al. R. Negative regulation of diacylglycerol kinase theta mediates adenosine-dependent hepatocyte preconditioning. Cell Death Differ 2010; 17: 1059-1068.
39. Hausenloy DJ, Yellon DM,. Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 2006; 70: 240-253.
40. Cai Z, Semenza G,. PTEN activity is modulated during ischemia and reperfusion: involvement in the induction and decay of preconditioning. Circ Res 2005; 97: 1351-1359.
41. Stocker H, Andjelkovic M, Oldham S, Laffargue M, Wymann MP, Hemmings BA, Hafen E,. Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB. Science 2002; 295: 2088-2091. (Pubitemid 34229473)
42. Brown DI, Griendling KK,. Nox proteins in signal transduction. Free Radic Biol Med 2009; 47: 1239-1253.
43. Ribé D, Sawbridge D, Thakur S, Hussey M, Ledent C, Kitchen I, et al. Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity. Free Radic Biol Med 2008; 44: 1433-1442.
44. Lee JH, Kim KY, Lee YK, Park SY, Kim CD, Lee WS, et al. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase tensin homologues deleted from chromosome 10 phosphorylation in rats. J Pharm Exp Ther 2004; 308: 896-903. (Pubitemid 38263963)
45. Wu DN, Pei DS, Wang Q, Zhang GY,. Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3K/Akt during cerebral ischemia in rat hippocampus. Neurosci Lett 2006; 404: 98-102. (Pubitemid 44041777)
46. Cai ZP, Shen Z, Van Kaer L, Becker LC,. Ischemic preconditioning-induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide-2 deficiency. FASEB J 2008; 22: 4248-4257.